Print


ISIN and CFI Database for Non-Russian Financial Instruments that Meet the Requirements of Bank of Russia Regulation on Qualification

The Database contains ISIN and CFI codes allocated by authorized agencies in accordance with ISO 6166 and ISO 10962, and the CFI codes meet the requirements of paragraph 4.2 of the Directive of the Central Bank of the Russian Federation No. 4561-U dated October 3, 2017 "On the Procedure for the Qualification of Foreign Financial Instruments as Securities" (in the version of the Directive of Bank of Russia No. 4903-U dated 12.09.2018).

Information on non-Russian financial instruments is updated in real time as a result of processing clients' new requests relating to new instruments, and upon completion of NSD's daily monitoring of information on instruments already recorded in the Database.

Information on ISIN and CFI codes is provided by NSD to market participants solely for the purpose of qualification of non-Russian financial instruments as securities admitted for operations on the Russian market*.

 
Search key:
 
31201-31220 of 80021 results shown.
ISIN Issuer; Country Issue Description CFI Code Edition of IS0 10962 ISIN Status [?] Numbering Agency Information Source As of
US23254L6039 CYCLACEL PHARMACEUTICALS INC; US COM PAR$.001 NEW ESVUFR 2015 Deleted Standard & Poor's - CUSIP Service Bureau, USA, UNITED STATES ASBF 2023-12-19
US23254L8019 CYCLACEL PHARMACEUTICALS INC; US COM PAR $.001 NEW 2023 ESVUFR 2015 New Standard & Poor's - CUSIP Service Bureau, USA, UNITED STATES ASB 2023-12-21
US23254W1045 CYCLONE PWR TECHNOLOGIES INC; US COM ESVUFR 2015 Updated Standard & Poor's - CUSIP Service Bureau, USA, UNITED STATES ASBF 2021-11-26
US23254X2018 CYCLO THERAPEUTICS INC; US COM NEW ESVUFR 2015 Updated Standard & Poor's - CUSIP Service Bureau, USA, UNITED STATES ASB 2023-12-21
US232553AA57 CYDSA S A B DE C V; MX SR NT 144A DBFNGR 2015 Updated Standard & Poor's - CUSIP Service Bureau, USA, UNITED STATES ASBF 2021-11-26
US23255M1053 CYCLERION THERAPEUTICS INC; US COM ESVUFR 2015 Deleted Standard & Poor's - CUSIP Service Bureau, USA, UNITED STATES ASBF 2023-05-17
US23255M2044 CYCLERION THERAPEUTICS INC; US COM NEW ESVUFR 2015 Updated Standard & Poor's - CUSIP Service Bureau, USA, UNITED STATES ASBF 2023-07-07
US2325772059 CYNOSURE INC; US CL A ESVUFR 2015 Updated Standard & Poor's - CUSIP Service Bureau, USA, UNITED STATES ASBF 2021-11-26
US23257B1070 CYNGN INC; US COM ESVUFR 2015 Updated Standard & Poor's - CUSIP Service Bureau, USA, UNITED STATES ASBF 2023-01-10
US23257D1037 CYMABAY THERAPEUTICS INC; US COM ESVUFR 2015 Updated Standard & Poor's - CUSIP Service Bureau, USA, UNITED STATES ASBF 2021-11-26
US23258P1057 CYNERGISTEK INC; US COM ESVUFR 2015 Updated Standard & Poor's - CUSIP Service Bureau, USA, UNITED STATES ASBF 2021-11-26
US2326745070 CYPRESS BIOSCIENCES INC; US COM PAR $.02 ESVUFR 2015 Updated Standard & Poor's - CUSIP Service Bureau, USA, UNITED STATES ASBF 2021-11-26
US2328061096 CYPRESS SEMICONDUCTOR CORP; US COM ESVUFR 2015 New Standard & Poor's - CUSIP Service Bureau, USA, UNITED STATES ASBF 2021-11-26
US23281A3077 CYPRESS SHARPRIDGE INVTS INC; US COM ESXXXX 2015 Deleted Standard & Poor's - CUSIP Service Bureau, USA, UNITED STATES ASBF 2021-11-26
US2328201007 CYTEC INDS INC; US COM ESVUFR 2015 Updated Standard & Poor's - CUSIP Service Bureau, USA, UNITED STATES ASBF 2021-11-26
US2328283013 LADRX CORP; US COM NEW ESXXXX 2015 Deleted Standard & Poor's - CUSIP Service Bureau, USA, UNITED STATES ASBF 2022-11-04
US2328285091 LADRX CORP; US COM PAR $.001 ESVUFR 2015 Deleted Standard & Poor's - CUSIP Service Bureau, USA, UNITED STATES ASBF 2022-11-04
US2328286081 LADRX CORP; US COM PAR $.001 NEW ESVUFR 2015 Deleted Standard & Poor's - CUSIP Service Bureau, USA, UNITED STATES ASBF 2023-05-18
US23282W1009 CYTOKINETICS INC; US COM ESVUFR 2015 Deleted Standard & Poor's - CUSIP Service Bureau, USA, UNITED STATES ASBF 2021-11-26
US23282W6057 CYTOKINETICS INC; US COM NEW ESVUFR 2015 Updated Standard & Poor's - CUSIP Service Bureau, USA, UNITED STATES ASBF 2021-11-26

* NSD does not make any representation or warranty as to the completeness or reliability of the information contained herein, nor does it make any warranty regarding its consistency with the purposes for which the information is used, including but not limited to, commercial purposes. The information published on this website is not to be construed as an offer to effect any deal with financial instruments, and should not be used for commercial or other purposes; nor does it represent an offer from NSD to render any services; nor does it make any warranty or representation of reliability of certain financial instruments or persons (including but not limited to, issuers, securities market participants, etc.).


For further information, please refer to NSD’s experts.

Printed version

Print